Emcure Pharmaceuticals, backed by Bain Capital, is set to launch its IPO on July 3. The IPO includes fresh equity shares issuance and Offer of Sale. Proceeds will be used for debt payment and corporate purposes.
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
